Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122193552 | 12219355 | 2 | F | 20160721 | 20160329 | 20160729 | EXP | CA-PFIZER INC-2015100474 | PFIZER | 61.00 | YR | F | Y | 0.00000 | 20160729 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
122193552 | 12219355 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 25 MG, WEEKLY | 11719 | 25 | MG | /wk | |||||||
122193552 | 12219355 | 2 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, 2X/DAY | 203214 | 5 | MG | TABLET | BID | ||||||
122193552 | 12219355 | 3 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | 300 MG, EVERY 8 WEEKS | N | 0 | 300 | MG | |||||||
122193552 | 12219355 | 4 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 20 MG, DAILY | N | 0 | 20 | MG | TABLET | ||||||
122193552 | 12219355 | 5 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | N | 0 | |||||||||
122193552 | 12219355 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | 8 MG/KG, UNK | N | 0 | 8 | MG/KG | ||||||||
122193552 | 12219355 | 7 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | 200 MG, UNK | N | 0 | 200 | MG | ||||||||
122193552 | 12219355 | 8 | SS | ORENCIA | ABATACEPT | 1 | 750 MG, MONTHLY | N | 0 | 750 | MG | /month | |||||||
122193552 | 12219355 | 9 | SS | SIMPONI | GOLIMUMAB | 1 | 50 MG, MONTHLY | N | 0 | 50 | MG | /month | |||||||
122193552 | 12219355 | 10 | C | INSULIN | INSULIN NOS | 1 | Oral | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
122193552 | 12219355 | 1 | Rheumatoid arthritis |
122193552 | 12219355 | 2 | Rheumatoid arthritis |
122193552 | 12219355 | 3 | Rheumatoid arthritis |
122193552 | 12219355 | 4 | Rheumatoid arthritis |
122193552 | 12219355 | 5 | Rheumatoid arthritis |
122193552 | 12219355 | 10 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
122193552 | 12219355 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
122193552 | 12219355 | Drug ineffective | |
122193552 | 12219355 | Headache | |
122193552 | 12219355 | Hepatotoxicity | |
122193552 | 12219355 | Insomnia | |
122193552 | 12219355 | Memory impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
122193552 | 12219355 | 1 | 200902 | 0 | ||
122193552 | 12219355 | 2 | 20150331 | 0 | ||
122193552 | 12219355 | 3 | 201002 | 201103 | 0 | |
122193552 | 12219355 | 4 | 200907 | 201102 | 0 | |
122193552 | 12219355 | 5 | 2014 | 0 | ||
122193552 | 12219355 | 6 | 201108 | 201111 | 0 | |
122193552 | 12219355 | 7 | 20110913 | 201202 | 0 | |
122193552 | 12219355 | 8 | 20120308 | 20150902 | 0 | |
122193552 | 12219355 | 9 | 201305 | 20131209 | 0 |